Resolution of inflammation: targeting GPCRs that interact with lipids and peptides

There is a growing appreciation of the important role of resolution mediators in the successful termination of the inflammatory response. Here, we discuss the potential importance of the lipid and peptide proresolving mediators, in particular the resolvins and chemerin-derived peptides, which mediate their effects through specific G protein-coupled receptors (GPCRs).

• Publication year

  2014

• Venue

  Drug Discovery Today

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.drudis.2014.06.023PMID 24993159PMCID 4154450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD73+ regulatory T cells contribute to adenosine‐mediated resolution of acute lung injury

  2013cited by this paper
• Resolvin E2 Formation and Impact in Inflammation Resolution

  2012cited by this paper
• The effect of galectins on leukocyte trafficking in inflammation: sweet or sour?

  2012cited by this paper
• Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis.

  2012cited by this paper
• Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses

  2012cited by this paper
• ChemR23 Dampens Lung Inflammation and Enhances Anti-viral Immunity in a Mouse Model of Acute Viral Pneumonia

  2011cited by this paper
• 17(R)‐Resolvin D1 differentially regulates TLR4‐mediated responses of primary human macrophages to purified LPS and live E. coli

  2011cited by this paper
• Resolvin D2 Is a Potent Endogenous Inhibitor for Transient Receptor Potential Subtype V1/A1, Inflammatory Pain, and Spinal Cord Synaptic Plasticity in Mice: Distinct Roles of Resolvin D1, D2, and E1

  2011cited by this paper
• Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.

  2011cited by this paper
• Novel anti-inflammatory--pro-resolving mediators and their receptors.

  2011cited by this paper
• The precursor of resolvin D series and aspirin‐triggered resolvin D1 display anti‐hyperalgesic properties in adjuvant‐induced arthritis in rats

  2011cited by this paper
• n-3 Fatty acids in cardiovascular disease.

  2011cited by this paper
• Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.

  2011cited by this paper
• n-3 fatty acids in cardiovascular disease.

  2011cited by this paper
• Immunopathology and Infectious Diseases Endogenous Galectin-1 and Acute Inflammation Emerging Notion of a Galectin-9 Pro-Resolving Effect

  2011cited by this paper
• Impaired Phagocytosis in Localized Aggressive Periodontitis: Rescue by Resolvin E1

  2011cited by this paper
• Regulation of Chemerin Chemoattractant and Antibacterial Activity by Human Cysteine Cathepsins

  2011cited by this paper
• Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals.

  2010cited by this paper
• Chemerin Peptides Promote Phagocytosis in a ChemR23- and Syk-Dependent Manner

  2010cited by this paper
• Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.

  2010cited by this paper
• Resolvin D1 binds human phagocytes with evidence for proresolving receptors

  2010cited by this paper
• Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation

  2010cited by this paper
• Profiling in resolving inflammatory exudates identifies novel anti‐inflammatory and pro‐resolving mediators and signals for termination

  2010cited by this paper
• Resolvin E1 Regulates Adenosine Diphosphate Activation of Human Platelets

  2010cited by this paper
• Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model1

  2009cited by this paper
• Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

  2009cited by this paper
• The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung Injury

  2009cited by this paper
• Endogenous galectins and the control of the host inflammatory response.

  2009cited by this paper
• Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis.

  2009cited by this paper
• Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

  2009cited by this paper
• Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

  2009cited by this paper
• Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ PUFA, inflammatory processes and rheumatoid arthritis

  2008cited by this paper
• Synthetic chemerin-derived peptides suppress inflammation through ChemR23

  2008cited by this paper
• The genetic design of signaling cascades to record receptor activation

  2008cited by this paper
• Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

  2008cited by this paper
• Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis

  2008cited by this paper
• G Protein Activation by the Leukotriene B4 Receptor Dimer

  2008cited by this paper
• Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.

  2007cited by this paper
• Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL2312

  2007cited by this paper
• Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness1

  2007cited by this paper
• The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues.

  2007cited by this paper
• Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation1

  2007cited by this paper
• Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice.

  2007cited by this paper
• Resolvin E1 and protectin D1 activate inflammation-resolution programmes

  2007cited by this paper
• Resolution of in flammation: state of the art, definitions and terms

  2006cited by this paper
• The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage.

  2006cited by this paper
• Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.

  2006cited by this paper
• Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

  2005cited by this paper
• Human mitochondria‐derived N‐formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes‐derived peptides preferentially activate FPR

  2005cited by this paper
• Neutrophil-Mediated Maturation of Chemerin: A Link between Innate and Adaptive Immunity1

  2005cited by this paper
• Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades*

  2005cited by this paper
• Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin

  2005cited by this paper
• Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages*

  2005cited by this paper
• Chemokine-Like Receptor 1 Expression and Chemerin-Directed Chemotaxis Distinguish Plasmacytoid from Myeloid Dendritic Cells in Human Blood1

  2005cited by this paper
• Inflammatory Resolution: new opportunities for drug discovery

  2004cited by this paper
• Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes1

  2004cited by this paper
• Humanin, a Newly Identified Neuroprotective Factor, Uses the G Protein-Coupled Formylpeptide Receptor-Like-1 as a Functional Receptor1

  2004cited by this paper
• A truncated form of CKβ8‐1 is a potent agonist for human formyl peptide‐receptor‐like 1 receptor

  2004cited by this paper
• N-Formylated humanin activates both formyl peptide receptor-like 1 and 2.

  2004cited by this paper
• Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R.

  2003cited by this paper
• Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids

  2003cited by this paper
• Drug discovery today.

  2003cited by this paper
• Murine Macrophages Produce Secretory Leukocyte Protease Inhibitor During Clearance of Apoptotic Cells: Implications for Resolution of the Inflammatory Response 1

  2003cited by this paper
• Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense

  2003cited by this paper
• BLT1 and BLT2: the leukotriene B(4) receptors.

  2003cited by this paper
• Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

  2002cited by this paper
• The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R

  2002cited by this paper
• The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2*

  2001cited by this paper
• The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.

  2001cited by this paper
• Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: focus on neutrophil recruitment.

  2001cited by this paper
• Natural and synthetic agonists of the melanocortin receptor type 3 possess anti‐inflammatory properties

  2001cited by this paper
• Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106–126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 11 2

  2001cited by this paper
• Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1

  2000cited by this paper
• A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR.

  2000cited by this paper
• Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells

  2000cited by this paper
• POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation.

  1999cited by this paper
• Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.

  1999cited by this paper
• 1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast‐supporting stromal cells

  1999cited by this paper
• A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells

  1999cited by this paper
• Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis

  1999cited by this paper
• Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin.

  1997cited by this paper
• Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor

  1994cited by this paper
• Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1.

  1993cited by this paper
• Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody.

  1993cited by this paper
• Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA.

  1990cited by this paper

• From Lead to Clinical Candidate: Discovery of BMS-986331 as a Potent and Selective N-Formyl Peptide Receptor 2 Agonist.

  2026cites this paper
• Adjunctive Therapies in Periodontitis: Current Concepts and the Future.

  2026cites this paper
• Chemerin 15 enhances microglial phagocytosis to attenuate cerebral ischemia-reperfusion injury through the ChemR23/p38 MAPK pathway

  2025cites this paper
• Molecular Mechanism Study of Dietary Fiber Lignin Intervention in Ulcerative Colitis through GPR37.

  2024cites this paper
• Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 Agonists.

  2024cites this paper
• Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction

  2023cites this paper
• Plasma Chemerin Is Induced in Critically Ill Patients with Gram-Positive Infections

  2023cites this paper
• Unlocking the power of NOX2: A comprehensive review on its role in immune regulation

  2023cites this paper
• Effect of non-surgical periodontal treatment on visfatin and chemerin concentration in the gingival crevicular fluid

  2023cites this paper
• Urinary chemerin as a potential biomarker for inflammatory bowel disease

  2022cites this paper
• Inflammation‐Controlled Anti‐Inflammatory Hydrogels

  2022cites this paper
• Role of macrophages during skeletal muscle regeneration and hypertrophy—Implications for immunomodulatory strategies

  2022cites this paper
• Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection

  2022cites this paper
• Targeting Angiogenesis via Resolution of Inflammation.

  2022cites this paper
• Molecular Pharmacology of Inflammation Resolution in Atherosclerosis

  2022cites this paper
• Specialized Pro-Resolving Mediators Do Not Inhibit the Synthesis of Inflammatory Mediators Induced by Tumor Necrosis Factor-α in Synovial Fibroblasts.

  2022cites this paper
• Potential role of bioactive lipids in rheumatoid arthritis.

  2021cites this paper
• The Utilisation of Resolvins in Medicine and Tissue Engineering.

  2021cites this paper
• COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention

  2021cites this paper
• Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma

  2021influential citation
• Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis

  2021cites this paper
• Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities

  2021cites this paper
• Therapeutic Opportunities for Repair GPCRs during Intestinal Mucosal Wound Healing.

  2020cites this paper
• PERİODONTAL ENFEKSİYONUN TEŞHİS VE PROGNOZUNDA UMUT VADEDEN BİYOBELİRTEÇLER

  2020cites this paper
• GPCR-PEnDB: a database of protein sequences and derived features to facilitate prediction and classification of G protein-coupled receptors

  2020cites this paper
• Could Arachidonic Acid-Derived Pro-Resolving Mediators Be a New Therapeutic Strategy for Asthma Therapy?

  2020cites this paper
• The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection

  2020cites this paper
• Molecular mechanisms of cardiovascular calcification

  2019cites this paper
• Biased perspectives on formyl peptide receptors.

  2019cites this paper
• The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation

  2019cites this paper
• Initiation, Propagation and Resolution of Inflammation

  2019cites this paper
• Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.

  2019cites this paper
• Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure.

  2019cites this paper
• Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes.

  2018cites this paper
• A model for the optimization of anti-inflammatory treatment with chemerin

  2018cites this paper
• Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619

  2018cites this paper
• Resolvin E1 (RvE1) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes

  2018cites this paper
• Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia

  2018cites this paper
• Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury

  2018cites this paper
• Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease

  2018cites this paper
• n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis

  2018cites this paper
• Immunomodulatory effect of specialised pro-resolving mediators in humans

  2017cites this paper
• Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice

  2017cites this paper
• Integration on Ligand and Structure Based Approaches in GPCRs

  2017cites this paper
• Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways

  2017cites this paper
• New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution

  2017influential citation
• ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance

  2017cites this paper
• Hydroalcoholic crude extract of Casearia sylvestris Sw. reduces chronic post-ischemic pain by activation of pro-resolving pathways.

  2017cites this paper
• Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes

  2016cites this paper
• Fine-tuning inflammation-resolution programs: focus on atherosclerosis

  2016cites this paper
• Effect of hexanic and hydroalcoholic extract of Cannabis sativa flowers on inflammatory paw edema in Rats

  2016cites this paper
• Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer

  2016cites this paper
• Triggering receptor expressed on myeloid cells and 5’adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target

  2016cites this paper
• Inflammation and chemerin in colorectal cancer

  2016cites this paper
• The peptidomimetic Lau-(Lys-βNSpe)6-NH2 antagonizes formyl peptide receptor 2 expressed in mouse neutrophils.

  2016cites this paper
• Resolution of inflammation: a new therapeutic frontier

  2016cites this paper
• Analgesic and Anti-Inflammatory Effects of Hydroalcoholic Extract of Salvia multicaulis on Male Rats

  2016cites this paper
• ANALGESIC AND ANTI-INFLAMMATORY EFFECTS OF HYDROALCOHOLIC EXTRACT OF SALVIA MULTICAULIS ON MALE RATS

  2015cites this paper
• Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?

  2015cites this paper
• The evolution of our understanding of macrophages and translation of findings toward the clinic

  2015cites this paper
• Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth.

  2015cites this paper
• The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders

  2015cites this paper
• Pathogenesis of rheumatoid arthritis: from systemic autoimmunity to localised joint disease.

  2014cites this paper